A detailed history of Suvretta Capital Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 1,866,361 shares of RPRX stock, worth $58.9 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares
1,866,361
Previous 1,866,361 -0.0%
Holding current value
$58.9 Million
Previous $49.2 Million 7.28%
% of portfolio
2.08%
Previous 2.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $10.1 Million - $11.5 Million
-384,000 Reduced 17.06%
1,866,361 $49.2 Million
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $45 Million - $51.3 Million
-1,637,341 Reduced 42.12%
2,250,361 $68.3 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $5.45 Million - $6.08 Million
-208,043 Reduced 5.08%
3,887,702 $109 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $27.5 Million - $32.9 Million
1,048,696 Added 34.42%
4,095,745 $111 Million
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $35.1 Million - $42.3 Million
1,072,424 Added 54.31%
3,047,049 $110 Million
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $5.17 Million - $5.81 Million
131,907 Added 7.16%
1,974,625 $78 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $49.3 Million - $55.2 Million
-1,235,788 Reduced 40.14%
1,842,718 $74 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $39.5 Million - $46.6 Million
1,052,896 Added 51.98%
3,078,506 $129 Million
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $2.19 Million - $2.48 Million
58,337 Added 2.97%
2,025,610 $78.9 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $15.5 Million - $18.7 Million
439,373 Added 28.76%
1,967,273 $78.4 Million
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $28.9 Million - $33.7 Million
798,523 Added 109.48%
1,527,900 $55.2 Million
Q2 2021

Aug 16, 2021

SELL
$39.85 - $46.63 $9.07 Million - $10.6 Million
-227,676 Reduced 23.79%
729,377 $29.9 Million
Q1 2021

May 17, 2021

SELL
$42.34 - $52.82 $110 Million - $137 Million
-2,599,880 Reduced 73.09%
957,053 $41.7 Million
Q4 2020

Feb 16, 2021

BUY
$36.12 - $50.05 $26.9 Million - $37.3 Million
744,552 Added 26.47%
3,556,933 $178 Million
Q3 2020

Nov 16, 2020

BUY
$38.56 - $48.36 $25.4 Million - $31.9 Million
659,381 Added 30.63%
2,812,381 $118 Million
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $95.8 Million - $112 Million
2,153,000 New
2,153,000 $105 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.8B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.